ACRS - Aclaris Therapeutics EPS misses by $0.04 beats on revenue February, 25 2021 07:27 AM Aclaris Therapeutics Inc. Aclaris Therapeutics (ACRS): Q4 GAAP EPS of -$0.30 misses by $0.04.Revenue of $1.58M (+43.6% Y/Y) beats by $0.19M.Shares -3.2% PM.Press Release For further details see: Aclaris Therapeutics EPS misses by $0.04, beats on revenue